formaldehyde has been researched along with Cancer of Prostate in 110 studies
paraform: polymerized formaldehyde; RN given refers to parent cpd; used in root canal therapy
| Excerpt | Relevance | Reference |
|---|---|---|
| " Accumulated evidence shows that endogenous formaldehyde concentrations are elevated in the blood or urine of patients with breast, prostate or bladder cancer." | 7.76 | Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain. ( Duan, B; Han, Y; Li, H; Liu, F; Luo, H; Luo, W; Maoying, Q; Tan, H; Tong, Z; Wan, Y; Wang, J; Wang, Y; Xu, T; Yang, F; Zhao, H, 2010) |
| " Accumulated evidence shows that endogenous formaldehyde concentrations are elevated in the blood or urine of patients with breast, prostate or bladder cancer." | 3.76 | Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain. ( Duan, B; Han, Y; Li, H; Liu, F; Luo, H; Luo, W; Maoying, Q; Tan, H; Tong, Z; Wan, Y; Wang, J; Wang, Y; Xu, T; Yang, F; Zhao, H, 2010) |
| "The contemporary problem of prostate cancer overtreatment can be partially attributed to the diagnosis of potentially indolent prostate cancers that pose low risk to aged men, and lack of sufficiently accurate risk stratification methods to reliably seek out men with indolent diseases." | 2.48 | Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data. ( De Marzo, AM; Dunn, TA; Fedor, HL; Luo, J, 2012) |
| "A number of bladder cancer case-control studies have noted an association with work as a machinist." | 2.40 | Oils and cancer. ( Tolbert, PE, 1997) |
| "Prostate cancer is the most common cancer in males worldwide." | 1.72 | A prostate cancer tissue specific spectral library for targeted proteomic analysis. ( Chen, L; Chen, S; Ding, X; Ge, W; Guo, T; Liang, S; Lyu, M; Sun, R; Wang, Y; Zhang, C; Zhou, Y, 2022) |
| "Malignant regions within prostate cancer samples more frequently contained cells with low Complex I & IV and high mitochondrial mass in comparison to benign-adjacent regions." | 1.72 | Automated quantitative high-throughput multiplex immunofluorescence pipeline to evaluate OXPHOS defects in formalin-fixed human prostate tissue. ( Brown, MD; Carey, CD; Clarke, NW; Greaves, LC; Hart, CA; Heer, R; Oliveira, P; Sachdeva, A; Turnbull, DM; Vincent, AE, 2022) |
| "From 63 prostate cancers examined, 59(94%) of the samples yielded at least 30 ng of DNA, the minimum amount of DNA considered suitable for NGS analysis." | 1.42 | Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing. ( Anderson, E; Ball, R; Brewer, DS; Clark, J; Cooper, C; Curley, H; Flather, M; Goody, V; Gundem, G; Hurst, R; Keeling, M; Manson-Bahr, D; McDermott, U; Mills, R; O'Meara, S; Rochester, M; Sethia, K; Yazbek-Hanna, M, 2015) |
| "The probability of prostate cancer detection is related to the amount of tissue represented." | 1.42 | Prostate Biopsy Core Handling: Comparison of Contemporary Preembedding Methods. ( Dellmann, A; Donhuijsen, K; Hammerer, PG; Pryalukhin, AE; Vandromme, A, 2015) |
| "We used two cell lines, DU145 (prostate cancer) and SKOV3 (ovarian cancer), grew them on coverslips and fixed them with 10% NBF at room temperature for 5 min and 12, 15, 18, 36, 108 and 180 h." | 1.39 | Preservation of immunorecognition by transferring cells from 10% neutral buffered formalin to 70% ethanol. ( Grizzle, WE; He, Q; Otali, D; Stockard, CR, 2013) |
| "In addition, 101 PCa patient samples, 13 benign prostatic hyperplasia (BPH) and 12 normal adjacent tissue samples, were assayed by PS and SS to evaluate their detection abilities for K-Ras mutations in codons 12 and 13." | 1.38 | Application of pyrosequencing technique for improved detection of K-Ras mutation in formalin-fixed and paraffin-embedded prostate carcinoma tissues in Chinese patients. ( Bo, J; Huang, Y; Li, D; Liang, G; Liu, D; Liu, W; Pan, J; Ping, P; Sha, J; Shen, W; Xuan, H, 2012) |
| "We present an example from a prostate cancer study using formalin-fixed paraffin-embedded tissue." | 1.37 | Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer. ( Bonnel, D; Day, R; Fournier, I; Franck, J; Gosset, P; Longuespee, R; Roudbaraki, M; Salzet, M, 2011) |
| "In the context of prostate cancer, this implies profiling in the diagnostic formalin-fixed, paraffin-embedded (FFPE) transrectal ultrasound-guided (TRUS) needle biopsy." | 1.37 | Laser-capture microdissection and transcriptional profiling in archival FFPE tissue in prostate cancer. ( Gnanapragasam, VJ; Joseph, A, 2011) |
| "In assessing the prevalence of XMRV in prostate cancer tissue samples we discovered that eluates from naïve DNA purification columns, when subjected to PCR with primers designed to detect genomic mouse DNA contamination, occasionally gave rise to amplification products." | 1.37 | DNA extraction columns contaminated with murine sequences. ( Dustan, S; Erlwein, O; Kaye, S; McClure, MO; Robinson, MJ; Weber, J, 2011) |
| "Diagnosis of prostate cancer (PCa) typically relies on needle biopsies, which are routinely archived in paraffin after formalin fixation and may contain valuable risk or prognostic information." | 1.36 | mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials. ( Gallagher, L; Gann, PH; Nonn, L; Vaishnav, A, 2010) |
| "This formamide-based method was applied to 46 formalin-fixed/paraffin-embedded (FFPE) biopsy tissue specimens from well-characterized patients with primary prostate cancer." | 1.35 | Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens. ( Barker, MA; Boyd, VL; Groshen, S; Imam, SA; Jones, LW; Kaur, P; Zon, G, 2009) |
| "Identification of prostate cancer associated-gene expression alterations such as AMACR, Kallikrein gene family and genes associated with androgen signaling such as PDEF and STEAP were consistent with previous findings reported in prostate cancer." | 1.35 | Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens. ( Dobi, A; Furusato, B; McLeod, DG; Nau, ME; Petrovics, G; Ravindranath, L; Seifert, M; Sesterhenn, IA; Shaheduzzaman, S; Srivastava, S; Vahey, M; Werner, T, 2008) |
| "We have used prostate cancer, the most commonly diagnosed noncutaneous neoplasm among men, to investigate the feasibility of performing genomic array analyses of archival tissue." | 1.32 | High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays. ( Albertson, DG; Alers, JC; Andaya, A; Carroll, P; Collins, C; Fridlyand, J; Jain, AN; Kamkar, S; Kowbel, D; Krijtenburg, PJ; Paris, PL; Pinkel, D; Schröder, FH; Van Dekken, H; Vissers, KJ; Watson, VJ; Wildhagen, MF, 2003) |
| "The pain was treated with lidocaine ointment and sitz baths with partial success." | 1.31 | Complications following formalin installation in the treatment of radiation induced proctitis. ( Belin, B; Efron, J; Nogueras, JJ; Pikarsky, AJ; Weiss, EG; Wexner, SD, 2000) |
| "In 14 cases of moderate and high-grade prostate cancer with metastases to lymph nodes, we found 34 beta E12 positivity in 6 (43%) of 14 metastases and in 7 (54%) of 13 primary tumors." | 1.30 | Anticytokeratin antibody 34 beta E12 staining in prostate carcinoma. ( Fitzgibbon, JF; Googe, PB; McGinley, KM, 1997) |
| "The TP53 gene mutation pattern in prostatic cancer was examined in relation to progression and survival, using archival formalin-fixed pre- and post-treatment tumour specimens from 84 prostatic cancer patients." | 1.29 | TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue. ( Berner, A; Børresen, AL; Fosså, SD; Geitvik, G; Karlsen, F; Nesland, JM, 1995) |
| "Seven patients had had cancer of the uterine cervix, and one patient had had cancer of the prostate treated with radiotherapy at a median time of 30 months (range, 9-46 months) previously." | 1.29 | A simple and effective treatment for hemorrhagic radiation proctitis using formalin. ( Eu, KW; Goh, HS; Ho, YH; Seow-Choen, F; Tay, SK, 1993) |
| "Recent animal studies found nasal cancer among rats exposed to formaldehyde, but no excess of this tumor occurred in this study." | 1.27 | Mortality among industrial workers exposed to formaldehyde. ( Bales, R; Blair, A; Cubit, D; Gaffey, W; Kaplan, S; O'Berg, M; Stewart, P; Walrath, J; Ward, J, 1986) |
| "All carcinomas (primary focus or metastasis) of non prostatic origin (55) stained negatively with the developed antiserum." | 1.26 | Demonstration of the prostatic origin of metastases: an immunohistochemical method for formalin-fixed embedded tissue. ( Anholt, RR; De Vries, GP; Jöbsis, AC; Sanders, GT, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (9.09) | 18.7374 |
| 1990's | 16 (14.55) | 18.2507 |
| 2000's | 32 (29.09) | 29.6817 |
| 2010's | 44 (40.00) | 24.3611 |
| 2020's | 8 (7.27) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, R | 1 |
| Lyu, M | 1 |
| Liang, S | 1 |
| Ge, W | 1 |
| Wang, Y | 2 |
| Ding, X | 1 |
| Zhang, C | 1 |
| Zhou, Y | 1 |
| Chen, S | 1 |
| Chen, L | 1 |
| Guo, T | 1 |
| Sachdeva, A | 1 |
| Hart, CA | 1 |
| Carey, CD | 1 |
| Vincent, AE | 1 |
| Greaves, LC | 1 |
| Heer, R | 1 |
| Oliveira, P | 1 |
| Brown, MD | 1 |
| Clarke, NW | 1 |
| Turnbull, DM | 1 |
| Bozgeyik, E | 1 |
| Ceylan, O | 1 |
| Mantsiou, A | 1 |
| Makridakis, M | 1 |
| Fasoulakis, K | 1 |
| Katafigiotis, I | 1 |
| Constantinides, CA | 1 |
| Zoidakis, J | 1 |
| Roubelakis, MG | 1 |
| Vlahou, A | 1 |
| Lygirou, V | 1 |
| Ali, F | 1 |
| Hu, KY | 1 |
| de Schaetzen van Brienen, L | 1 |
| Larmuseau, M | 1 |
| Van der Eecken, K | 1 |
| De Ryck, F | 1 |
| Robbe, P | 1 |
| Schuh, A | 1 |
| Fostier, J | 1 |
| Ost, P | 1 |
| Marchal, K | 1 |
| Ebrahimizadeh, W | 1 |
| Guérard, KP | 1 |
| Rouzbeh, S | 1 |
| Bramhecha, YM | 1 |
| Scarlata, E | 1 |
| Brimo, F | 1 |
| Patel, PG | 1 |
| Jamaspishvili, T | 1 |
| Aprikian, AG | 1 |
| Berman, D | 1 |
| Bartlett, JMS | 1 |
| Chevalier, S | 1 |
| Lapointe, J | 1 |
| Buszewska-Forajta, M | 1 |
| Raczak-Gutknecht, J | 1 |
| Artymowicz, M | 1 |
| Wesołowski, W | 1 |
| Buczkowski, K | 1 |
| Iżycka-Świeszewska, E | 1 |
| Markuszewski, MJ | 1 |
| Nikitina, AS | 1 |
| Sharova, EI | 1 |
| Danilenko, SA | 1 |
| Butusova, TB | 1 |
| Vasiliev, AO | 1 |
| Govorov, AV | 1 |
| Prilepskaya, EA | 1 |
| Pushkar, DY | 1 |
| Kostryukova, ES | 1 |
| FitzGerald, LM | 1 |
| Raspin, K | 1 |
| Marthick, JR | 1 |
| Field, MA | 1 |
| Malley, RC | 1 |
| Thomson, RJ | 1 |
| Blackburn, NB | 1 |
| Banks, A | 1 |
| Charlesworth, JC | 1 |
| Donovan, S | 1 |
| Dickinson, JL | 1 |
| Eryilmaz, IE | 1 |
| Aytac Vuruskan, B | 1 |
| Kaygısız, O | 1 |
| Egeli, U | 1 |
| Tunca, B | 1 |
| Kordan, Y | 1 |
| Cecener, G | 1 |
| Carlsson, J | 1 |
| Davidsson, S | 1 |
| Fridfeldt, J | 1 |
| Giunchi, F | 1 |
| Fiano, V | 1 |
| Grasso, C | 1 |
| Zelic, R | 1 |
| Richiardi, L | 1 |
| Andrén, O | 1 |
| Pettersson, A | 1 |
| Fiorentino, M | 2 |
| Akre, O | 1 |
| Hagen, RM | 2 |
| Rhodes, A | 2 |
| Oxley, J | 2 |
| Ladomery, MR | 2 |
| Samalavicius, NE | 1 |
| Dulskas, A | 1 |
| Kilius, A | 1 |
| Petrulis, K | 1 |
| Norkus, D | 1 |
| Burneckis, A | 1 |
| Valuckas, KP | 1 |
| Yeoh, E | 1 |
| Tam, W | 1 |
| Schoeman, M | 1 |
| Moore, J | 1 |
| Thomas, M | 1 |
| Botten, R | 1 |
| Di Matteo, A | 1 |
| Davalieva, K | 1 |
| Kiprijanovska, S | 1 |
| Polenakovic, M | 1 |
| Miller, JK | 1 |
| Buchner, N | 1 |
| Timms, L | 1 |
| Tam, S | 1 |
| Luo, X | 1 |
| Brown, AM | 1 |
| Pasternack, D | 1 |
| Bristow, RG | 1 |
| Fraser, M | 1 |
| Boutros, PC | 1 |
| McPherson, JD | 1 |
| Long, Q | 1 |
| Xu, J | 2 |
| Osunkoya, AO | 1 |
| Sannigrahi, S | 1 |
| Johnson, BA | 1 |
| Zhou, W | 1 |
| Gillespie, T | 1 |
| Park, JY | 1 |
| Nam, RK | 1 |
| Sugar, L | 1 |
| Stanimirovic, A | 1 |
| Seth, AK | 1 |
| Petros, JA | 1 |
| Moreno, CS | 1 |
| Powers, TW | 1 |
| Neely, BA | 1 |
| Shao, Y | 1 |
| Tang, H | 1 |
| Troyer, DA | 1 |
| Mehta, AS | 1 |
| Haab, BB | 1 |
| Drake, RR | 1 |
| Adamo, P | 1 |
| Karamat, S | 1 |
| Aning, JJ | 1 |
| Gillatt, D | 1 |
| Persad, R | 1 |
| Manson-Bahr, D | 1 |
| Ball, R | 1 |
| Gundem, G | 1 |
| Sethia, K | 1 |
| Mills, R | 1 |
| Rochester, M | 1 |
| Goody, V | 1 |
| Anderson, E | 1 |
| O'Meara, S | 1 |
| Flather, M | 1 |
| Keeling, M | 1 |
| Yazbek-Hanna, M | 1 |
| Hurst, R | 1 |
| Curley, H | 1 |
| Clark, J | 2 |
| Brewer, DS | 1 |
| McDermott, U | 1 |
| Cooper, C | 1 |
| Brzezinska, EA | 1 |
| Nixon, C | 1 |
| Patel, R | 1 |
| Leung, HY | 2 |
| Grasso, CS | 1 |
| Cani, AK | 1 |
| Hovelson, DH | 1 |
| Quist, MJ | 1 |
| Douville, NJ | 1 |
| Yadati, V | 1 |
| Amin, AM | 1 |
| Nelson, PS | 1 |
| Betz, BL | 1 |
| Liu, CJ | 1 |
| Knudsen, KE | 1 |
| Cooney, KA | 1 |
| Feng, FY | 1 |
| McDaniel, AS | 1 |
| Tomlins, SA | 1 |
| Pryalukhin, AE | 1 |
| Vandromme, A | 1 |
| Dellmann, A | 1 |
| Donhuijsen, K | 1 |
| Hammerer, PG | 1 |
| Wagner, J | 1 |
| Damaschke, N | 1 |
| Yang, B | 1 |
| Truong, M | 1 |
| Guenther, C | 1 |
| McCormick, J | 1 |
| Huang, W | 1 |
| Jarrard, D | 1 |
| Tyekucheva, S | 1 |
| Martin, NE | 1 |
| Stack, EC | 1 |
| Wei, W | 1 |
| Vathipadiekal, V | 1 |
| Waldron, L | 1 |
| Lis, RT | 1 |
| Stampfer, MJ | 1 |
| Loda, M | 1 |
| Parmigiani, G | 1 |
| Mucci, LA | 1 |
| Birrer, M | 1 |
| Thompson, ML | 1 |
| Jimenez-Andrade, JM | 1 |
| Chartier, S | 1 |
| Tsai, J | 1 |
| Burton, EA | 1 |
| Habets, G | 1 |
| Lin, PS | 1 |
| West, BL | 1 |
| Mantyh, PW | 1 |
| Dziki, Ł | 1 |
| Kujawski, R | 1 |
| Mik, M | 1 |
| Berut, M | 1 |
| Dziki, A | 1 |
| Trzciński, R | 1 |
| Reynolds, HM | 1 |
| Williams, S | 1 |
| Zhang, A | 1 |
| Chakravorty, R | 1 |
| Rawlinson, D | 1 |
| Ong, CS | 1 |
| Esteva, M | 1 |
| Mitchell, C | 1 |
| Parameswaran, B | 1 |
| Finnegan, M | 1 |
| Liney, G | 1 |
| Haworth, A | 1 |
| Mihala, A | 1 |
| Alexa, AA | 1 |
| Samoilă, C | 1 |
| Dema, A | 1 |
| Vizitiu, AC | 1 |
| Anghel, A | 1 |
| Tămaş, L | 1 |
| Marian, CV | 1 |
| Sîrbu, IO | 1 |
| Peng, Z | 1 |
| Andersson, K | 1 |
| Lindholm, J | 1 |
| Dethlefsen, O | 1 |
| Pramana, S | 1 |
| Pawitan, Y | 1 |
| Nistér, M | 1 |
| Nilsson, S | 1 |
| Li, C | 1 |
| Panderi, I | 1 |
| Yakirevich, E | 1 |
| Papagerakis, S | 1 |
| Noble, L | 1 |
| Lombardo, K | 1 |
| Pantazatos, D | 1 |
| Peskoe, SB | 1 |
| Barber, JR | 1 |
| Zheng, Q | 1 |
| Meeker, AK | 1 |
| De Marzo, AM | 4 |
| Platz, EA | 1 |
| Lupold, SE | 1 |
| Singla, N | 1 |
| Walker, J | 1 |
| Woldu, SL | 1 |
| Passoni, NM | 1 |
| de la Fuente, K | 1 |
| Roehrborn, CG | 1 |
| Doak, SH | 1 |
| Rogers, D | 1 |
| Jones, B | 1 |
| Francis, L | 1 |
| Conlan, RS | 1 |
| Wright, C | 1 |
| Agell, L | 1 |
| Hernández, S | 1 |
| de Muga, S | 1 |
| Lorente, JA | 1 |
| Juanpere, N | 1 |
| Esgueva, R | 1 |
| Serrano, S | 1 |
| Gelabert, A | 1 |
| Lloreta, J | 1 |
| Lutz, BR | 1 |
| Dentinger, CE | 1 |
| Nguyen, LN | 1 |
| Sun, L | 1 |
| Zhang, J | 1 |
| Allen, AN | 2 |
| Chan, S | 1 |
| Knudsen, BS | 2 |
| Zon, G | 1 |
| Barker, MA | 1 |
| Kaur, P | 1 |
| Groshen, S | 1 |
| Jones, LW | 1 |
| Imam, SA | 1 |
| Boyd, VL | 1 |
| McCarthy, F | 2 |
| Fletcher, A | 1 |
| Dennis, N | 2 |
| Cummings, C | 1 |
| O'Donnell, H | 1 |
| Flohr, P | 2 |
| Vergis, R | 1 |
| Jhavar, S | 2 |
| Parker, C | 2 |
| Cooper, CS | 2 |
| Patel, P | 1 |
| Subhas, G | 1 |
| Gupta, A | 1 |
| Chang, YJ | 1 |
| Mittal, VK | 1 |
| McKendrick, A | 1 |
| Nonn, L | 1 |
| Vaishnav, A | 1 |
| Gallagher, L | 1 |
| Gann, PH | 2 |
| Otali, D | 2 |
| Stockard, CR | 2 |
| Oelschlager, DK | 1 |
| Wan, W | 1 |
| Manne, U | 1 |
| Watts, SA | 1 |
| Grizzle, WE | 2 |
| Tong, Z | 1 |
| Luo, W | 1 |
| Yang, F | 1 |
| Han, Y | 1 |
| Li, H | 1 |
| Luo, H | 1 |
| Duan, B | 1 |
| Xu, T | 1 |
| Maoying, Q | 1 |
| Tan, H | 1 |
| Wang, J | 1 |
| Zhao, H | 1 |
| Liu, F | 1 |
| Wan, Y | 1 |
| Jaraj, SJ | 1 |
| Egevad, L | 2 |
| Bonnel, D | 1 |
| Longuespee, R | 1 |
| Franck, J | 1 |
| Roudbaraki, M | 1 |
| Gosset, P | 1 |
| Day, R | 1 |
| Salzet, M | 1 |
| Fournier, I | 1 |
| Joseph, A | 1 |
| Gnanapragasam, VJ | 2 |
| Erlwein, O | 1 |
| Robinson, MJ | 1 |
| Dustan, S | 1 |
| Weber, J | 1 |
| Kaye, S | 1 |
| McClure, MO | 1 |
| Lotan, TL | 1 |
| Gurel, B | 1 |
| Sutcliffe, S | 1 |
| Esopi, D | 1 |
| Liu, W | 2 |
| Hicks, JL | 1 |
| Park, BH | 1 |
| Humphreys, E | 1 |
| Partin, AW | 1 |
| Han, M | 1 |
| Netto, GJ | 1 |
| Isaacs, WB | 1 |
| Kerick, M | 1 |
| Isau, M | 1 |
| Timmermann, B | 1 |
| Sültmann, H | 1 |
| Herwig, R | 1 |
| Krobitsch, S | 1 |
| Schaefer, G | 1 |
| Verdorfer, I | 1 |
| Bartsch, G | 1 |
| Klocker, H | 1 |
| Lehrach, H | 1 |
| Schweiger, MR | 1 |
| Bourne, RM | 2 |
| Kurniawan, N | 2 |
| Cowin, G | 2 |
| Stait-Gardner, T | 2 |
| Sved, P | 2 |
| Watson, G | 2 |
| Chowdhury, S | 1 |
| Price, WS | 2 |
| Dunn, TA | 1 |
| Fedor, HL | 1 |
| Luo, J | 1 |
| Al-Amin, A | 1 |
| Cowley, R | 1 |
| Scott, N | 1 |
| Sha, J | 1 |
| Liang, G | 1 |
| Pan, J | 1 |
| Xuan, H | 1 |
| Ping, P | 1 |
| Li, D | 1 |
| Bo, J | 1 |
| Liu, D | 1 |
| Shen, W | 1 |
| Huang, Y | 1 |
| Ortiz-Rey, JA | 1 |
| San Miguel-Fraile, P | 1 |
| Gómez de María, C | 1 |
| Huri de Lama, S | 1 |
| Rodríguez Sánchez, MC | 1 |
| Menon, R | 1 |
| Deng, M | 1 |
| Boehm, D | 2 |
| Braun, M | 1 |
| Fend, F | 1 |
| Biskup, S | 1 |
| Perner, S | 1 |
| Beltran, H | 1 |
| Yelensky, R | 1 |
| Frampton, GM | 1 |
| Park, K | 1 |
| Downing, SR | 1 |
| MacDonald, TY | 1 |
| Jarosz, M | 1 |
| Lipson, D | 1 |
| Tagawa, ST | 1 |
| Nanus, DM | 1 |
| Stephens, PJ | 1 |
| Mosquera, JM | 1 |
| Cronin, MT | 1 |
| Rubin, MA | 2 |
| He, Q | 1 |
| Fordyce, CA | 1 |
| Heaphy, CM | 1 |
| Griffith, JK | 1 |
| Fedor, HH | 1 |
| Gage, WR | 1 |
| Paris, PL | 2 |
| Albertson, DG | 2 |
| Alers, JC | 1 |
| Andaya, A | 1 |
| Carroll, P | 1 |
| Fridlyand, J | 1 |
| Jain, AN | 1 |
| Kamkar, S | 1 |
| Kowbel, D | 1 |
| Krijtenburg, PJ | 1 |
| Pinkel, D | 2 |
| Schröder, FH | 2 |
| Vissers, KJ | 1 |
| Watson, VJ | 1 |
| Wildhagen, MF | 1 |
| Collins, C | 2 |
| Van Dekken, H | 2 |
| Shi, SR | 1 |
| Cote, RJ | 1 |
| Liu, C | 1 |
| Yu, MC | 1 |
| Castelao, JE | 1 |
| Ross, RK | 1 |
| Taylor, CR | 1 |
| Leiva, IM | 1 |
| Emmert-Buck, MR | 1 |
| Gillespie, JW | 1 |
| DELORY, GE | 1 |
| SWEETSER, TH | 1 |
| WHITE, TA | 1 |
| Cogan, PS | 1 |
| Koch, TH | 1 |
| Bibikova, M | 2 |
| Yeakley, JM | 1 |
| Chudin, E | 2 |
| Chen, J | 1 |
| Wickham, E | 1 |
| Wang-Rodriguez, J | 2 |
| Fan, JB | 2 |
| van Duin, M | 1 |
| van Marion, R | 1 |
| Watson, JE | 1 |
| Lapuk, A | 1 |
| Brown, N | 1 |
| Oseroff, VV | 1 |
| de Jong, P | 1 |
| Nacheva, EP | 1 |
| Dinjens, W | 1 |
| Konishi, T | 1 |
| Watanabe, T | 1 |
| Kitayama, J | 1 |
| Shibahara, J | 1 |
| Nagawa, H | 1 |
| Ananthanarayanan, V | 1 |
| Pins, MR | 1 |
| Meyer, RE | 1 |
| Yuyama, H | 1 |
| Koakutsu, A | 1 |
| Fujiyasu, N | 1 |
| Fujimori, A | 1 |
| Sato, S | 1 |
| Shibasaki, K | 1 |
| Tanaka, S | 1 |
| Sudoh, K | 1 |
| Sasamata, M | 1 |
| Miyata, K | 1 |
| Miyoshi, Y | 1 |
| Uemura, H | 1 |
| Ishiguro, H | 1 |
| Kitamura, H | 1 |
| Nomura, N | 1 |
| Danenberg, PV | 1 |
| Kubota, Y | 1 |
| Hood, BL | 2 |
| Darfler, MM | 1 |
| Guiel, TG | 1 |
| Furusato, B | 2 |
| Lucas, DA | 1 |
| Ringeisen, BR | 1 |
| Sesterhenn, IA | 2 |
| Conrads, TP | 2 |
| Veenstra, TD | 2 |
| Krizman, DB | 1 |
| Hwang, SI | 1 |
| Thumar, J | 1 |
| Lundgren, DH | 1 |
| Rezaul, K | 1 |
| Mayya, V | 1 |
| Wu, L | 1 |
| Eng, J | 1 |
| Wright, ME | 1 |
| Han, DK | 1 |
| Jonmarker, S | 1 |
| Valdman, A | 1 |
| Lindberg, A | 1 |
| Hellström, M | 1 |
| Arsanjani, A | 1 |
| Zhou, L | 1 |
| Garcia, EW | 1 |
| Modder, J | 1 |
| Kostelec, M | 1 |
| Barker, D | 1 |
| Downs, T | 1 |
| Shaheduzzaman, S | 1 |
| Petrovics, G | 1 |
| Dobi, A | 1 |
| Seifert, M | 1 |
| Ravindranath, L | 1 |
| Nau, ME | 1 |
| Werner, T | 1 |
| Vahey, M | 1 |
| McLeod, DG | 1 |
| Srivastava, S | 1 |
| McLerran, DF | 1 |
| Vessella, RL | 1 |
| Karademos, J | 1 |
| Davies, JE | 1 |
| Maqsodi, B | 1 |
| McMaster, GK | 1 |
| Kristal, AR | 1 |
| Rogerson, L | 1 |
| Darby, S | 1 |
| Jabbar, T | 1 |
| Mathers, ME | 1 |
| Robson, CN | 1 |
| Sahadevan, K | 1 |
| O'Toole, K | 1 |
| Rouzier, C | 1 |
| Haudebourg, J | 1 |
| Carpentier, X | 1 |
| Valério, L | 1 |
| Amiel, J | 1 |
| Michiels, JF | 1 |
| Pedeutour, F | 1 |
| Srivastava, PK | 1 |
| Küffer, S | 1 |
| Brors, B | 1 |
| Shahi, P | 1 |
| Li, L | 1 |
| Kenzelmann, M | 1 |
| Gretz, N | 1 |
| Gröne, HJ | 1 |
| Noordzij, MA | 1 |
| van der Kwast, TH | 1 |
| van Steenbrugge, GJ | 1 |
| van Weerden, WM | 1 |
| Oomen, MH | 1 |
| Berner, A | 1 |
| Geitvik, G | 1 |
| Karlsen, F | 2 |
| Fosså, SD | 1 |
| Nesland, JM | 1 |
| Børresen, AL | 1 |
| Mathai, V | 1 |
| Seow-Choen, F | 2 |
| Kalantari, M | 1 |
| Chitemerere, M | 1 |
| Johansson, B | 1 |
| Hagmar, B | 1 |
| Boon, ME | 1 |
| van der Poel, HG | 1 |
| Tan, CJ | 1 |
| Kok, LP | 1 |
| Goh, HS | 1 |
| Eu, KW | 1 |
| Ho, YH | 1 |
| Tay, SK | 1 |
| Stattin, P | 1 |
| Damber, JE | 1 |
| Karlberg, L | 1 |
| Bergh, A | 1 |
| Googe, PB | 1 |
| McGinley, KM | 1 |
| Fitzgibbon, JF | 1 |
| Chiusa, L | 1 |
| Galliano, D | 1 |
| Formiconi, A | 1 |
| Di Primio, O | 1 |
| Pich, A | 1 |
| Vince, DG | 1 |
| Tbakhi, A | 1 |
| Gaddipati, A | 1 |
| Cothren, RM | 1 |
| Cornhill, JF | 1 |
| Tubbs, RR | 1 |
| Tolbert, PE | 1 |
| Botticelli, AR | 1 |
| Casali, AM | 1 |
| Botticelli, L | 1 |
| Zaffe, D | 1 |
| Dent, OF | 1 |
| Galt, E | 1 |
| Chapuis, PH | 1 |
| Yuile, P | 1 |
| Sinclair, G | 1 |
| Bokey, EL | 1 |
| Sramkoski, RM | 1 |
| Wormsley, SW | 1 |
| Bolton, WE | 1 |
| Crumpler, DC | 1 |
| Jacobberger, JW | 1 |
| Varma, M | 1 |
| Linden, MD | 1 |
| Amin, MB | 1 |
| Spanel, P | 1 |
| Smith, D | 1 |
| Holland, TA | 1 |
| Al Singary, W | 1 |
| Elder, JB | 1 |
| Pikarsky, AJ | 1 |
| Belin, B | 1 |
| Efron, J | 1 |
| Weiss, EG | 1 |
| Nogueras, JJ | 1 |
| Wexner, SD | 1 |
| Gown, AM | 1 |
| Yaziji, H | 1 |
| Battifora, H | 1 |
| Cohen, RJ | 1 |
| Beales, MP | 1 |
| McNeal, JE | 1 |
| Jöbsis, AC | 1 |
| De Vries, GP | 1 |
| Anholt, RR | 1 |
| Sanders, GT | 1 |
| Helms, SR | 1 |
| Brattain, MG | 1 |
| Pretlow, TG | 1 |
| Kreisberg, JI | 1 |
| Stonington, OG | 1 |
| Szwec, N | 1 |
| Webber, M | 1 |
| Abel, PD | 1 |
| Keane, P | 1 |
| Leathem, A | 1 |
| Tebbutt, S | 1 |
| Williams, G | 1 |
| Nakamura, K | 1 |
| Simon, AL | 1 |
| Kasabian, NG | 1 |
| Addonizio, JC | 1 |
| Choudhury, M | 1 |
| Nagamatsu, GR | 1 |
| Rossi, JA | 1 |
| Chiao, JW | 1 |
| Blair, A | 1 |
| Stewart, P | 1 |
| O'Berg, M | 1 |
| Gaffey, W | 1 |
| Walrath, J | 1 |
| Ward, J | 1 |
| Bales, R | 1 |
| Kaplan, S | 1 |
| Cubit, D | 1 |
| Ochiai, K | 1 |
| Takeuchi, H | 1 |
| Roy, AV | 1 |
| Brower, ME | 1 |
| Hayden, JE | 1 |
| Kreutzmann, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Trial to Investigate the Infectious Outcomes of Intrarectal Povidone-iodine Cleansing Plus Formalin Disinfection of Needle Tip During Transrectal Ultrasound Guided Prostate Biopsy[NCT03879486] | 1,257 participants (Actual) | Interventional | 2017-05-31 | Completed | |||
| Phase II Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian and Primary Peritoneal Carcinoma[NCT00868192] | Phase 2 | 38 participants (Actual) | Interventional | 2008-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
"Overall response rate = complete response + partial response~Complete response = disappearance of all target and non-target lesions and no evidence of new lesions documented by two disease assessments at least 4 weeks apart.~Partial response = at least a 30% decrease in the sum of the longest dimensions (LD) of all target measurable lesions taking as reference the baseline sum of LD. There can be non unequivocal progression of non-target lesions and no new lesions." (NCT00868192)
Timeframe: 6 months
| Intervention | percentage of participants (Number) |
|---|---|
| Pemetrexed and Bevacizumab | 41 |
OS = observed length of time from entry into the study to death or date of last contact (NCT00868192)
Timeframe: 12 months
| Intervention | percentage of participants (Number) |
|---|---|
| Pemetrexed and Bevacizumab | 79 |
OS = observed length of time from entry into the study to death or date of last contact (NCT00868192)
Timeframe: Median follow-up was 25.7 months (range 3.0-47.2 months)
| Intervention | months (Median) |
|---|---|
| Pemetrexed and Bevacizumab | 25.7 |
PFS = Period from study entry until disease progression, death, or date of last contact (NCT00868192)
Timeframe: 6 months
| Intervention | percentage of participants (Number) |
|---|---|
| Pemetrexed and Bevacizumab | 56 |
PFS = Period from study entry until disease progression, death, or date of last contact (NCT00868192)
Timeframe: Median follow-up was 25.7 months (range 3.0-47.2 months)
| Intervention | months (Median) |
|---|---|
| Pemetrexed and Bevacizumab | 7.9 |
A CA-125 response was defined as at least a 50% reduction in CA-125 levels from a pretreatment sample following guidelines described by the Gynecological Cancer Intergroup. (NCT00868192)
Timeframe: 6 months
| Intervention | participants (Number) | ||
|---|---|---|---|
| 50% CA-125 response | 75% CA-125 response | No CA-125 response | |
| Pemetrexed and Bevacizumab | 17 | 8 | 2 |
OS = observed length of time from entry into the study to death or date of last contact (NCT00868192)
Timeframe: Median follow-up was 25.7 months (range 3.0-47.2 months)
| Intervention | months (Median) | ||
|---|---|---|---|
| Platinum-free interval of <6 months | Platinum-free interval of 6-12 months | Platinum-free interval of >12 months | |
| Pemetrexed and Bevacizumab | 16.7 | 24.9 | 28.0 |
PFS = Period from study entry until disease progression, death, or date of last contact (NCT00868192)
Timeframe: Median follow-up was 25.7 months (range 3.0-47.2 months)
| Intervention | months (Median) | ||
|---|---|---|---|
| Platinum-free interval of <6 months | Platinum-free interval of 6-12 months | Platinum-free interval of >12 months | |
| Pemetrexed and Bevacizumab | 6.7 | 4.7 | 16.8 |
As measured by RECIST criteria (NCT00868192)
Timeframe: 6 months
| Intervention | participants (Number) | |||
|---|---|---|---|---|
| Complete response | Partial response | Stable disease | Progressive disease | |
| Pemetrexed and Bevacizumab | 0 | 14 | 18 | 2 |
Detailed serious adverse events and other adverse events are shown in the adverse event module of the results. (NCT00868192)
Timeframe: 6 months
| Intervention | percentage of participants (Number) | ||||
|---|---|---|---|---|---|
| Grade 3/4 hematologic toxicity | Most common non-hematologic toxicity - fatigue | Grade 3 renal toxicity | Gastrointestinal toxicity | Subsequently developed hematologic malignancies | |
| Pemetrexed and Bevacizumab | 53 | 94 | 6 | 91 | 6 |
4 reviews available for formaldehyde and Cancer of Prostate
| Article | Year |
|---|---|
Molecular profiling of indolent human prostate cancer: tackling technical challenges to achieve high-fidelity genome-wide data.
Topics: Biomarkers, Tumor; Disease Progression; DNA, Neoplasm; Epigenesis, Genetic; Formaldehyde; Gene Expre | 2012 |
Handling of clinical tissue specimens for molecular profiling studies.
Topics: Cryopreservation; DNA, Complementary; Formaldehyde; Gene Expression Profiling; Humans; Internet; Mal | 2003 |
Oils and cancer.
Topics: 2-Naphthylamine; Benzo(a)pyrene; Carcinogens; Chlorine Compounds; Esophageal Neoplasms; Ethanolamine | 1997 |
[Acid phosphatase--how to read its figures].
Topics: Acid Phosphatase; Clinical Enzyme Tests; Ethanol; Formaldehyde; Glycerophosphates; Hot Temperature; | 1971 |
2 trials available for formaldehyde and Cancer of Prostate
| Article | Year |
|---|---|
Argon plasma coagulation therapy versus topical formalin for intractable rectal bleeding and anorectal dysfunction after radiation therapy for prostate carcinoma.
Topics: Administration, Topical; Aged; Aged, 80 and over; Anal Canal; Argon Plasma Coagulation; Coagulants; | 2013 |
Exome enrichment and SOLiD sequencing of formalin fixed paraffin embedded (FFPE) prostate cancer tissue.
Topics: Cryopreservation; Exome; Formaldehyde; High-Throughput Nucleotide Sequencing; Humans; Male; Paraffin | 2012 |
104 other studies available for formaldehyde and Cancer of Prostate
| Article | Year |
|---|---|
A prostate cancer tissue specific spectral library for targeted proteomic analysis.
Topics: Formaldehyde; Humans; Male; Mass Spectrometry; Paraffin Embedding; Prostatic Neoplasms; Proteins; Pr | 2022 |
Automated quantitative high-throughput multiplex immunofluorescence pipeline to evaluate OXPHOS defects in formalin-fixed human prostate tissue.
Topics: Electron Transport Complex IV; Fluorescent Antibody Technique; Formaldehyde; Humans; Male; Oxidative | 2022 |
Distinct expression signatures of miR-130a, miR-301a, miR-454 in formalin fixed paraffin embedded tissue samples of prostate cancer patients.
Topics: Biomarkers, Tumor; Formaldehyde; Humans; Male; MicroRNAs; Paraffin Embedding; Prostatic Neoplasms | 2022 |
Proteomics Analysis of Formalin Fixed Paraffin Embedded Tissues in the Investigation of Prostate Cancer.
Topics: Animals; Chromatography, Liquid; Formaldehyde; Humans; Male; Mice; Paraffin Embedding; Prostatic Neo | 2020 |
Evaluation and Management of Chronic Radiation Proctitis.
Topics: Administration, Rectal; Aged; Chronic Disease; Formaldehyde; Humans; Male; Proctitis; Prostatic Neop | 2020 |
Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples.
Topics: Biomarkers, Tumor; DNA, Neoplasm; Feasibility Studies; Formaldehyde; Gene Expression Profiling; Gene | 2020 |
Design and Development of a Fully Synthetic Multiplex Ligation-Dependent Probe Amplification-Based Probe Mix for Detection of Copy Number Alterations in Prostate Cancer Formalin-Fixed, Paraffin-Embedded Tissue Samples.
Topics: Cell Line, Tumor; DNA Copy Number Variations; DNA Probes; DNA, Neoplasm; Formaldehyde; Genome, Human | 2020 |
The potential role of fatty acids in prostate cancer determined by GC-MS analysis of formalin-fixed paraffin-embedded tissue samples.
Topics: Fatty Acids; Formaldehyde; Gas Chromatography-Mass Spectrometry; Humans; Male; Metabolomics; Paraffi | 2021 |
Novel RNA biomarkers of prostate cancer revealed by RNA-seq analysis of formalin-fixed samples obtained from Russian patients.
Topics: Aged; Formaldehyde; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulato | 2017 |
Impact of the G84E variant on HOXB13 gene and protein expression in formalin-fixed, paraffin-embedded prostate tumours.
Topics: Alleles; Case-Control Studies; Cohort Studies; DNA Methylation; Formaldehyde; Gene Expression; Genet | 2017 |
RNA-based markers in biopsy cores with atypical small acinar proliferation: Predictive effect of T2E fusion positivity and MMP-2 upregulation for a subsequent prostate cancer diagnosis.
Topics: Aged; Biomarkers, Tumor; Biopsy, Large-Core Needle; Disease-Free Survival; Formaldehyde; Humans; Mal | 2019 |
Quantity and quality of nucleic acids extracted from archival formalin fixed paraffin embedded prostate biopsies.
Topics: Biopsy; Female; Fixatives; Formaldehyde; Humans; Male; Nucleic Acids; Paraffin Embedding; Prostate; | 2018 |
A M-MLV reverse transcriptase with reduced RNaseH activity allows greater sensitivity of gene expression detection in formalin fixed and paraffin embedded prostate cancer samples.
Topics: Formaldehyde; Gene Expression Profiling; Humans; Limit of Detection; Male; Moloney murine leukemia v | 2013 |
Treatment of hemorrhagic radiation-induced proctopathy with a 4% formalin application under perianal anesthetic infiltration.
Topics: Administration, Rectal; Aged; Anesthesia, Local; Drug Administration Schedule; Formaldehyde; Gastroi | 2013 |
Assessment of the 2-d gel-based proteomics application of clinically archived formalin-fixed paraffin embedded tissues.
Topics: Biomarkers, Tumor; Breast; Breast Neoplasms; Cryopreservation; Electrophoresis, Gel, Two-Dimensional | 2014 |
Use of Sequenom sample ID Plus® SNP genotyping in identification of FFPE tumor samples.
Topics: DNA, Neoplasm; Fixatives; Formaldehyde; Genetic Markers; Genotyping Techniques; Humans; Male; Micros | 2014 |
Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence.
Topics: Adult; Biomarkers, Tumor; Fixatives; Formaldehyde; Gene Expression Profiling; Humans; Kaplan-Meier E | 2014 |
MALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarrays.
Topics: Adult; Animals; Carbohydrate Sequence; Carcinoma, Hepatocellular; Female; Formaldehyde; Humans; Hydr | 2014 |
Quantitative analysis of ERG expression and its splice isoforms in formalin-fixed, paraffin-embedded prostate cancer samples: association with seminal vesicle invasion and biochemical recurrence.
Topics: Alternative Splicing; Exons; Formaldehyde; Gene Expression Regulation, Neoplastic; Humans; Immunohis | 2014 |
Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing.
Topics: Aged; Biomarkers, Tumor; Biopsy, Fine-Needle; DNA Mutational Analysis; Fixatives; Formaldehyde; Gene | 2015 |
Genetically engineered mouse models to study prostate cancer.
Topics: Animals; Disease Models, Animal; Dissection; Eosine Yellowish-(YS); Formaldehyde; Genetic Engineerin | 2015 |
Integrative molecular profiling of routine clinical prostate cancer specimens.
Topics: Biomarkers, Tumor; Biopsy; DNA Copy Number Variations; DNA Mutational Analysis; Feasibility Studies; | 2015 |
Prostate Biopsy Core Handling: Comparison of Contemporary Preembedding Methods.
Topics: Biopsy, Large-Core Needle; Formaldehyde; Glass; Humans; Male; Materials Testing; Paper; Prostate; Pr | 2015 |
Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence.
Topics: Aged; Antineoplastic Agents; Aziridines; Benzoquinones; beta-Galactosidase; Biomarkers; Cellular Sen | 2015 |
Comparing Platforms for Messenger RNA Expression Profiling of Archival Formalin-Fixed, Paraffin-Embedded Tissues.
Topics: Clinical Trials, Phase III as Topic; Female; Formaldehyde; Gene Expression Profiling; Humans; Male; | 2015 |
Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancer.
Topics: Aminopyridines; Analgesics; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Bone a | 2015 |
Formalin therapy for hemorrhagic radiation proctitis.
Topics: Administration, Rectal; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Argon; Asp | 2015 |
Development of a registration framework to validate MRI with histology for prostate focal therapy.
Topics: Aged; Atlases as Topic; Cell Count; Fixatives; Formaldehyde; Gels; Histological Techniques; Humans; | 2015 |
A pilot study on the expression of microRNAs resident on chromosome 21 in laser microdissected FFPE prostate adenocarcinoma samples.
Topics: Adenocarcinoma; Chromosomes, Human, Pair 21; Formaldehyde; Gene Expression Regulation, Neoplastic; H | 2015 |
Improving the Prediction of Prostate Cancer Overall Survival by Supplementing Readily Available Clinical Data with Gene Expression Levels of IGFBP3 and F3 in Formalin-Fixed Paraffin Embedded Core Needle Biopsy Material.
Topics: Aged; Aged, 80 and over; Biopsy, Large-Core Needle; Cohort Studies; Formaldehyde; Gene Expression Re | 2016 |
Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data.
Topics: Adenocarcinoma; Biomarkers, Tumor; Formaldehyde; Humans; Male; Paraffin Embedding; Principal Compone | 2017 |
Differential long-term stability of microRNAs and RNU6B snRNA in 12-20 year old archived formalin-fixed paraffin-embedded specimens.
Topics: Formaldehyde; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; Paraffin Embedding; P | 2017 |
Formalin disinfection of prostate biopsy needles may reduce post-biopsy infectious complications.
Topics: Aged; Anti-Bacterial Agents; Biopsy, Needle; Disinfection; Formaldehyde; Humans; Male; Middle Aged; | 2017 |
High-resolution imaging using a novel atomic force microscope and confocal laser scanning microscope hybrid instrument: essential sample preparation aspects.
Topics: Cell Line, Tumor; Fixatives; Formaldehyde; Humans; Image Processing, Computer-Assisted; Intercellula | 2008 |
KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations.
Topics: Artifacts; Base Sequence; DNA Mutational Analysis; Formaldehyde; Humans; Kruppel-Like Factor 6; Krup | 2008 |
Spectral analysis of multiplex Raman probe signatures.
Topics: Automation; Biological Assay; Fluorescent Dyes; Formaldehyde; Humans; Keratin-18; Male; Nanoparticle | 2008 |
Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
Topics: Base Sequence; Biomarkers, Tumor; Biopsy; DNA Methylation; DNA, Neoplasm; Formaldehyde; Formamides; | 2009 |
An improved method for constructing tissue microarrays from prostate needle biopsy specimens.
Topics: Biomarkers, Tumor; Biopsy, Needle; Fixatives; Formaldehyde; Humans; In Situ Hybridization, Fluoresce | 2009 |
Oral vitamin A enhances the effectiveness of formalin 8% in treating chronic hemorrhagic radiation proctopathy.
Topics: Administration, Oral; Aged; Aged, 80 and over; Carcinoma; Cohort Studies; Dietary Supplements; Forma | 2009 |
mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials.
Topics: Biomarkers, Tumor; Biopsy, Needle; Feasibility Studies; Formaldehyde; Frozen Sections; Gene Expressi | 2010 |
Combined effects of formalin fixation and tissue processing on immunorecognition.
Topics: Antigens; Cell Line, Tumor; Ethanol; Female; Fixatives; Formaldehyde; Humans; Immunohistochemistry; | 2009 |
Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain.
Topics: Acids; Animals; Bone Neoplasms; Breast Neoplasms; CHO Cells; Cricetinae; Cricetulus; Female; Formald | 2010 |
Formalin fixation and immunoreactivity in prostate cancer and benign prostatic tissues.
Topics: Adenocarcinoma; Biomarkers, Tumor; Formaldehyde; Humans; Immunohistochemistry; Injections, Intralesi | 2010 |
High-density tissue microarrays from prostate needle biopsies.
Topics: Biomarkers, Tumor; Biopsy, Needle; Formaldehyde; Humans; Male; Prospective Studies; Prostatic Neopla | 2011 |
Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer.
Topics: Amino Acid Sequence; Animals; Biomarkers, Tumor; Formaldehyde; Humans; Male; Molecular Sequence Data | 2011 |
Laser-capture microdissection and transcriptional profiling in archival FFPE tissue in prostate cancer.
Topics: Fixatives; Formaldehyde; Gene Expression Profiling; Humans; Lasers; Male; Microdissection; Paraffin | 2011 |
DNA extraction columns contaminated with murine sequences.
Topics: Animals; Base Sequence; Biochemistry; DNA Contamination; DNA, Neoplasm; Formaldehyde; Humans; Leukem | 2011 |
PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.
Topics: Cell Line, Tumor; Cohort Studies; Formaldehyde; Gene Deletion; Humans; Immunohistochemistry; Male; P | 2011 |
Targeted high throughput sequencing in clinical cancer settings: formaldehyde fixed-paraffin embedded (FFPE) tumor tissues, input amount and tumor heterogeneity.
Topics: DNA Copy Number Variations; DNA, Neoplasm; Formaldehyde; Genetic Heterogeneity; Humans; Male; Paraff | 2011 |
Biexponential diffusion decay in formalin-fixed prostate tissue: preliminary findings.
Topics: Algorithms; Computer Simulation; Diffusion; Fixatives; Formaldehyde; Humans; Image Enhancement; Imag | 2012 |
Formalin dab for treatment of haemorrhagic radiation proctitis.
Topics: Administration, Topical; Aged; Formaldehyde; Gastrointestinal Hemorrhage; Humans; Male; Proctitis; P | 2011 |
Application of pyrosequencing technique for improved detection of K-Ras mutation in formalin-fixed and paraffin-embedded prostate carcinoma tissues in Chinese patients.
Topics: Aged; Asian People; Carcinoma; Case-Control Studies; Cell Line, Tumor; Codon; Fixatives; Formaldehyd | 2012 |
Microscopic diffusivity compartmentation in formalin-fixed prostate tissue.
Topics: Fixatives; Formaldehyde; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; P | 2012 |
A simple way to improve immunoreactivity of prostate needle biopsies fixed in Bouin's solution to AMACR.
Topics: Acetic Acid; Adenocarcinoma; Biopsy, Needle; Ethanol; Fixatives; Formaldehyde; Humans; Immunohistoch | 2013 |
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Biopsy, Needle; Drug Resistance, Neoplasm; Ex | 2013 |
Preservation of immunorecognition by transferring cells from 10% neutral buffered formalin to 70% ethanol.
Topics: Cell Line, Tumor; ErbB Receptors; Ethanol; Female; Fixatives; Formaldehyde; Humans; Immunohistochemi | 2013 |
Chemiluminescent measurement of telomere DNA content in biopsies.
Topics: Biopsy; Blotting, Southern; DNA; Female; Formaldehyde; HeLa Cells; Humans; Luminescent Measurements; | 2002 |
Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays.
Topics: Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Fixatives; Formaldehyde | 2002 |
High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays.
Topics: Chromosome Aberrations; Chromosome Mapping; Formaldehyde; Histological Techniques; Humans; Male; Neo | 2003 |
A modified reduced-temperature antigen retrieval protocol effective for use with a polyclonal antibody to cyclooxygenase-2 (PG 27).
Topics: Antibodies; Antigens; Breast Neoplasms; Cyclooxygenase 2; Female; Formaldehyde; Hot Temperature; Hum | 2002 |
The use of formalin and alcohol in the estimation of prostatic phosphatase.
Topics: Ethanol; Formaldehyde; Humans; Male; Phosphoric Monoester Hydrolases; Prostatic Neoplasms | 1951 |
Studies of targeting and intracellular trafficking of an anti-androgen doxorubicin-formaldehyde conjugate in PC-3 prostate cancer cells bearing androgen receptor-GFP chimera.
Topics: Androgen Antagonists; Doxorubicin; Formaldehyde; Green Fluorescent Proteins; Humans; Imidazoles; Lig | 2004 |
Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis.
Topics: Adenocarcinoma; Breast Neoplasms; Colonic Neoplasms; Female; Fixatives; Formaldehyde; Gene Expressio | 2004 |
Construction and application of a full-coverage, high-resolution, human chromosome 8q genomic microarray for comparative genomic hybridization.
Topics: Adenocarcinoma; Cardia; Chromosome Aberrations; Chromosomes, Human, Pair 8; Fixatives; Formaldehyde; | 2005 |
Endoscopic and histopathologic findings after formalin application for hemorrhage caused by chronic radiation-induced proctitis.
Topics: Aged; Fixatives; Formaldehyde; Gastrointestinal Hemorrhage; Humans; Male; Proctitis; Prostatic Neopl | 2005 |
Immunohistochemical assays in prostatic biopsies processed in Bouin's fixative.
Topics: Acetic Acid; Biomarkers, Tumor; Biopsy; Cell Cycle Proteins; Cell Nucleus; Cyclin-Dependent Kinase I | 2005 |
Inhibitory effects of a selective endothelin-A receptor antagonist YM598 on endothelin-1-induced potentiation of nociception in formalin-induced and prostate cancer-induced pain models in mice.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Behavior, Animal; Cell Line, Tumor; Disease | 2004 |
Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer.
Topics: Cell Differentiation; Dihydrouracil Dehydrogenase (NADP); DNA Primers; Formaldehyde; Gene Expression | 2005 |
Proteomic analysis of formalin-fixed prostate cancer tissue.
Topics: Amino Acid Sequence; Cytokines; Formaldehyde; Gene Expression Profiling; Gene Expression Regulation, | 2005 |
Unravelling the proteome of formalin-fixed paraffin-embedded tissue.
Topics: Animals; Biomarkers; Fixatives; Formaldehyde; Lasers; Male; Mass Spectrometry; Microdissection; Neop | 2006 |
Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues.
Topics: Amino Acid Sequence; Biomarkers, Tumor; Computational Biology; Formaldehyde; Humans; Immunohistochem | 2007 |
Tissue shrinkage after fixation with formalin injection of prostatectomy specimens.
Topics: Artifacts; Fixatives; Formaldehyde; Humans; Male; Organ Size; Prostatectomy; Prostatic Neoplasms; Ti | 2006 |
Expression signatures that correlated with Gleason score and relapse in prostate cancer.
Topics: Aged; Aged, 80 and over; Formaldehyde; Gene Expression Profiling; Humans; Male; Middle Aged; Oligonu | 2007 |
Transcriptome analyses of benign and malignant prostate epithelial cells in formalin-fixed paraffin-embedded whole-mounted radical prostatectomy specimens.
Topics: Adenocarcinoma; Dissection; Epithelial Cells; Formaldehyde; Gene Expression Profiling; Humans; Image | 2008 |
Evaluation of the branched-chain DNA assay for measurement of RNA in formalin-fixed tissues.
Topics: Animals; Biological Specimen Banks; Branched DNA Signal Amplification Assay; Formaldehyde; Gene Expr | 2008 |
Application of transcript profiling in formalin-fixed paraffin-embedded diagnostic prostate cancer needle biopsies.
Topics: Biopsy, Needle; Cell Line, Tumor; Cohort Studies; Feasibility Studies; Formaldehyde; Gene Expression | 2008 |
Detection of the TMPRSS2-ETS fusion gene in prostate carcinomas: retrospective analysis of 55 formalin-fixed and paraffin-embedded samples with clinical data.
Topics: Adenocarcinoma; Adenovirus E1A Proteins; Aged; Aged, 80 and over; DNA-Binding Proteins; Feasibility | 2008 |
A cut-off based approach for gene expression analysis of formalin-fixed and paraffin-embedded tissue samples.
Topics: Analysis of Variance; Fixatives; Formaldehyde; Gene Expression Profiling; Gene Expression Regulation | 2008 |
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissues.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Bromodeoxyuridine; Cell Division; Formaldehyde; Fro | 1995 |
TP53 mutations in prostatic cancer. Analysis of pre- and post-treatment archival formalin-fixed tumour tissue.
Topics: Aged; Aged, 80 and over; Electrophoresis; Formaldehyde; Genes, p53; Humans; Male; Middle Aged; Mutat | 1995 |
Endoluminal formalin therapy for haemorrhagic radiation proctitis.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Female; Formaldehyde; Gastrointestinal Hemorrhage; Hu | 1995 |
Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation.
Topics: Base Sequence; DNA; DNA Damage; DNA, Neoplasm; DNA, Viral; Formaldehyde; Humans; Kidney; Male; Molec | 1994 |
Effect of embedding methods versus fixative type on karyometric measures.
Topics: Cell Nucleus; Ethanol; Fixatives; Formaldehyde; Humans; Image Processing, Computer-Assisted; Karyome | 1994 |
A simple and effective treatment for hemorrhagic radiation proctitis using formalin.
Topics: Adult; Aged; Female; Follow-Up Studies; Formaldehyde; Gastrointestinal Hemorrhage; Humans; Male; Mid | 1993 |
Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer.
Topics: Aged; Aged, 80 and over; Cell Division; Formaldehyde; Humans; Immunohistochemistry; Ki-67 Antigen; M | 1997 |
Anticytokeratin antibody 34 beta E12 staining in prostate carcinoma.
Topics: Adenocarcinoma; Biomarkers, Tumor; Formaldehyde; Humans; Keratins; Lymphatic Metastasis; Male; Prost | 1997 |
High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Agents, Hormonal; Biopsy, Needle; Carc | 1997 |
Quantitative comparison of immunohistochemical staining intensity in tissues fixed in formalin and Histochoice.
Topics: Analysis of Variance; Antigens, CD20; Carcinoma; Chromogranins; Colonic Neoplasms; Factor VIII; Fixa | 1997 |
Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings
Topics: Aged; Biopsy, Needle; Cell Cycle; Cyclins; Evaluation Studies as Topic; Fixatives; Formaldehyde; Hum | 1998 |
Quality of life in patients undergoing treatment for chronic radiation-induced rectal bleeding.
Topics: Aged; Aged, 80 and over; Chronic Disease; Depression; Female; Formaldehyde; Gastrointestinal Hemorrh | 1998 |
Simultaneous detection of cyclin B1, p105, and DNA content provides complete cell cycle phase fraction analysis of cells that endoreduplicate.
Topics: Benzimidazoles; Cell Cycle; Cell Line; Cell Separation; Cells, Immobilized; Cyclin B; Cyclin B1; DNA | 1999 |
Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues.
Topics: Antibodies, Monoclonal; Epitopes; Formaldehyde; Histocytological Preparation Techniques; Hot Tempera | 1999 |
Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry.
Topics: Formaldehyde; Humans; Male; Mass Spectrometry; Prostatic Neoplasms; Urinary Bladder Neoplasms; Urine | 1999 |
Complications following formalin installation in the treatment of radiation induced proctitis.
Topics: Aged; Aged, 80 and over; Fecal Incontinence; Female; Formaldehyde; Gastrointestinal Hemorrhage; Huma | 2000 |
Correspondence re: Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on antibody 34betaE12 immunostaining of prostatic tissues. Mod Pathol 1999;12:472-8.
Topics: Antibodies, Monoclonal; Biomarkers, Tumor; Epitopes; Formaldehyde; Histocytological Preparation Tech | 2000 |
Prostate secretory granules in normal and neoplastic prostate glands: a diagnostic aid to needle biopsy.
Topics: Adenocarcinoma; Biopsy, Needle; Formaldehyde; Glutaral; Humans; Male; Prostate; Prostatic Intraepith | 2000 |
Demonstration of the prostatic origin of metastases: an immunohistochemical method for formalin-fixed embedded tissue.
Topics: Acid Phosphatase; Formaldehyde; Humans; Immunoenzyme Techniques; Isoenzymes; Male; Neoplasm Metastas | 1978 |
"Prostatic acid phosphatase?" A comparison of acid phosphatase activities in epithelial cells, granulocytes, monocytes, lymphocytes, and platelets purified by velocity sedimentation in isokinetic gradients of Ficoll in tissue culture medium.
Topics: Acid Phosphatase; Blood Platelets; Copper; Epithelial Cells; Epithelium; Fluorides; Formaldehyde; Gr | 1977 |
Isolation and identification of the human malignant prostatic epithelial cell in pure monolayer culture.
Topics: Acid Phosphatase; Cells, Cultured; Epithelial Cells; Epithelium; Formaldehyde; Humans; Lymphatic Met | 1975 |
Change in glycoconjugate for the binding site of the lectin Ulex europeus 1 following malignant transformation of prostatic epithelium.
Topics: Aged; Aged, 80 and over; Binding Sites; Cell Transformation, Neoplastic; Formaldehyde; Frozen Sectio | 1989 |
Flow cytometric analysis of relative mean DNA content of urogenital cancer cells in fresh and paraffin-embedded materials.
Topics: DNA, Neoplasm; Fixatives; Flow Cytometry; Formaldehyde; Histological Techniques; Humans; Kidney Neop | 1987 |
Mortality among industrial workers exposed to formaldehyde.
Topics: Adult; Environmental Exposure; Female; Formaldehyde; Hodgkin Disease; Humans; Industry; Leukemia; Lu | 1986 |
Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum.
Topics: Acid Phosphatase; Biliary Tract Diseases; Blood Platelets; Bone and Bones; Breast Neoplasms; Erythro | 1971 |
[Determination and establishment of normal limits of total and prostatic acid phosphatase activity].
Topics: Acid Phosphatase; Blood Platelets; Female; Formaldehyde; Germany, East; Humans; Male; Methods; Nitro | 1970 |